Delivery Order SPE2DB22D3009-SPE2DB25FAW72

Award Date 5/5/25
Potential Completion Date 5/6/25
Potential Value $11K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,540.64, is for the supply of SYNVISC-ONE SYRINGE 6ML, a medical product. The contract has a firm fixed price and runs until February 25, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued...
This is a delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The order is for Synvisc-One Syringes and has a ceiling value of $1,856.46. The contract is a firm-fixed price delivery order, with an ultimate completion date of September 5, 2024. This award is not associated with a set-aside program. Amerisourcebergen holds significant Indefinite Delivery Contracts (IDCs) with federal agencies,...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of SYNVISC-ONE SYRINGE 6ML. The contract has a ceiling value of $7,319.96 and is a firm-fixed price arrangement with an ultimate completion date of September 23, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued up to $999,999,999 through December 2025,...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The contract is for the supply of Synvisc-One syringes, a specialty pharmaceutical product, with a ceiling value of $1,644.56 and a performance period through March 13, 2024. This delivery order is issued under a larger indefinite delivery contract (IDC) awarded solely to...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of SYNVISC-ONE SYRINGE 6ML, a medical product, with a ceiling value of $1,856.46 and a period of performance through January 25, 2024. The contract was awarded on a firm fixed-price basis without any set-aside requirements, indicating open competition. AmerisourceBergen holds a...
This is a $11,455.88 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of SYNVISC-ONE SYRINGE 6ML medical products. The contract has an ultimate completion date of April 14, 2025 and was awarded on April 11, 2025. This contract is not designated as a set-aside and represents a standalone delivery order. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of SYNVISC-ONE syringes. The contract has a firm fixed price of $3,779.22 and an ultimate completion date of August 19, 2024. As the contract is not set aside for any specific business type, it was awarded to Amerisourcebergen's Corporate Office Division. Amerisourcebergen holds several Indefinite Delivery Contracts (IDCs) with federal...
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,397.11, is for the provision of SYNVISC-ONE SYRINGE 6ML, a medical product, under a firm fixed-price arrangement. The award is not set aside and is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA, valued at $999,999,999.00, which provides a...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $4,459.76, is for the supply of SYNVISC-ONE SYRINGE 6ML, a specialty medical product, with a period of performance through August 7, 2024. The contract is not designated as a set-aside. In addition to this specific delivery order, AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of SYNVISC-ONE SYRINGE 6ML, a medical product, with a ceiling value of $3,540.86 and a period of performance through January 22, 2025. The contract is a firm fixed-price delivery order with no set-aside designation, indicating open competition. AmerisourceBergen holds a...
  • SPE2DB22D3009
    Indefinite Delivery Contract
  • SPE2DB22D3009-SPE2DB25FAW72
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Synvisc-One syringe, a prescription medication used for the treatment of osteoarthritis. The contract has a ceiling value of $11,073.78 and a completion date of May 6, 2025. It is a firm fixed-price contract, with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp is the prime contractor, and the place of performance is Conshohocken, Pennsylvania. This contract is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle for the Defense Health Agency, U.S. Coast Guard, and other government agencies through December 2026.

Generated 8/4/25, 9:57 AM